The effectof norethynodrel, norethindrone and ethynodiol diacetate on hepatic microsomal drug metabolism.
D000633:Aminopyrine N-Demethylase / Q000037:antagonists & inhibitors; D000814:Aniline Compounds; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003579:Cytochrome Reductases / Q000037:antagonists & inhibitors; D005040:Ethynodiol Diacetate / Q000494:pharmacology*; D066298:In Vitro Techniques; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009640:Norethindrone / Q000494:pharmacology*; D009641:Norethynodrel / Q000494:pharmacology*; D010424:Pentobarbital / Q000378:metabolism / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000814:Aniline Compounds; D011374:Progesterone; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D000633:Aminopyrine N-Demethylase; D003579:Cytochrome Reductases; D010424:Pentobarbital; D009640:Norethindrone